A

搜索文档
Buxton Helmsley Releases Open Letter to Directors of Daily Journal Corporation
GlobeNewswire News Room· 2025-07-29 04:21
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Buxton Helmsley USA, Inc. (“BH”), a New York City-based alternative asset manager whose brand is recognized by Bloomberg as being among the top 15% of activist investors globally (based on number of investor advocacy campaigns), today released an open letter to the directors of the Daily Journal Corporation (the “Company” or “DJCO”), given a failure to timely react to a July 25, 2025, open letter to shareholders outlining concerns related to: (a) compliance with a ...
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2025
Prnewswire· 2025-07-29 04:21
Consolidated Results of Operations - Three-Month Periods Ended June 30, 2025 and 2024:KING OF PRUSSIA, Pa., July 28, 2025 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended June 30, 2025, net income was $4.5 million, or $.32 per diluted share, as compared to $5.3 million, or $.38 per diluted share, during the second quarter of 2024.The decrease in our net income of $784,000, or $.06 per diluted share, during the second quarter of 2025, as co ...
Equifax and Qlarifi Partner to Study Impact of Buy Now, Pay Later on Credit Risk and Fraud
Prnewswire· 2025-07-29 04:20
ATLANTA and LONDON, July 28, 2025 /PRNewswire/ -- Equifax® (NYSE: EFX) a global data, analytics and technology company, and Qlarifi, the first real-time consumer credit database purpose built for Buy Now, Pay Later lending, are partnering to conduct a joint study on the impact of BNPL reporting on credit risk assessments and fraud prevention. Qlarifi Logo According to a recent survey, more than 50% of U.S. consumers currently use BNPL for payment and 35% are planning on increasing their use in 2025. As ...
PTC Therapeutics Announces FDA Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
Prnewswire· 2025-07-29 04:19
- Broad labeling inclusive of all disease subtypes for individuals 1 month of age and older -- PTC will host a conference call on Monday, July 28th at 5:00 pm ET -WARREN, N.J., July 28, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has approved SEPHIENCE™ (sepiapterin) for the treatment of children and adults living with phenylketonuria (PKU). The approval includes broad labeling for the treatment of hyperphenylalaninemia (HPA) in ...
Materialise: Automotive Weakness Is Undermining The Stock
Seeking Alpha· 2025-07-29 04:18
Materialise NV (NASDAQ: MTLS ) reported soft results in the second quarter, which appear to have been driven by automotive headwinds in Europe, along with macro volatility reducing customer investment appetite. While this situation is likely to persist in the short term, Materialise's Medical segmentRichard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena believes that excess ri ...
Levi & Korsinsky Notifies Shareholders of iRobot Corporation (IRBT) of a Class Action Lawsuit and an Upcoming Deadline
GlobeNewswire News Room· 2025-07-29 04:16
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in iRobot Corporation ("iRobot Corporation" or the "Company") (NASDAQ: IRBT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of iRobot Corporation investors who were adversely affected by alleged securities fraud between January 29, 2024 and March 11, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/iro ...
Park National Corporation reports financial results for second quarter and first half of 2025
Globenewswire· 2025-07-29 04:15
NEWARK, Ohio, July 28, 2025 (GLOBE NEWSWIRE) -- Park National Corporation (Park) (NYSE American: PRK) today reported financial results for the second quarter and first half of 2025. Park's board of directors declared a quarterly cash dividend of $1.07 per common share, payable on September 10, 2025, to common shareholders of record as of August 15, 2025. “Our quarterly and mid-year performance reflects our organization’s soundness and our bankers’ unwavering dedication,” said Park Chairman and CEO David Tra ...
Highlights – June Quarter 2025
Globenewswire· 2025-07-29 04:15
Figure 10 AC collar locations over regional geological interpretation and airborne magnetics, showing maximum downhole gold values. Figure 11 Sherlock Crossing, showing extended soil anomaly > 15 ppm Sb to the SW of the proposed first pass drilling area at the Clarke Mine. Share Registry Share Registry Novo Exploration Map Novo Exploration Map Novo completed its maiden RC drill program at the Clone prospect as part of the Tibooburra Gold Project in May 2025 testing 500 m of strike. Drilling ...
Celestica Announces Second Quarter 2025 Financial Results
Globenewswire· 2025-07-29 04:15
(All amounts in U.S. dollars) Q2 2025 revenue and adjusted EPS* above the high end of our guidance ranges;Raising 2025 annual outlook TORONTO, July 28, 2025 (GLOBE NEWSWIRE) -- Celestica Inc.1 (TSX and NYSE: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world's most innovative companies, today announced financial results for the quarter ended June 30, 2025 (Q2 2025). Q2 2025 Highlights Revenue: $2.89 billion, increased 21% compared to $2.39 billion for second ...
NBT Bancorp Inc. Announces Second Quarter 2025 Net Income and Approves an 8.8% Cash Dividend Increase
Globenewswire· 2025-07-29 04:15
NORWICH, N.Y., July 28, 2025 (GLOBE NEWSWIRE) -- NBT Bancorp Inc. (“NBT” or the “Company”) (NASDAQ: NBTB) reported net income and diluted earnings per share for the three and six months ended June 30, 2025. Net income for the second quarter of 2025 was $22.5 million, or $0.44 per diluted common share, compared to $32.7 million, or $0.69 per diluted common share, for the second quarter of 2024, and $36.7 million, or $0.77 per diluted common share, for the first quarter of 2025. Operating diluted earnings per ...